JPS61152613A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPS61152613A JPS61152613A JP27941484A JP27941484A JPS61152613A JP S61152613 A JPS61152613 A JP S61152613A JP 27941484 A JP27941484 A JP 27941484A JP 27941484 A JP27941484 A JP 27941484A JP S61152613 A JPS61152613 A JP S61152613A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- ascorbic acid
- cosmetic
- effect
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、後記特定のアスコルビン酸誘導体を含有する
皮膚化粧料に関し、更に詳しくは、人体に好ましくない
副作用や皮膚刺激を有さず、長期保存しても安定で、し
かも優れた肌荒れ防止効果、皮膚の老化防止効果$よび
優れ九美白効果を同時に発現、付与し得る皮膚化粧料に
関する。Detailed Description of the Invention (Industrial Application Field) The present invention relates to a skin cosmetic containing a specific ascorbic acid derivative described below, and more specifically, it has no undesirable side effects or skin irritation on the human body, and has a long-term use. To provide a skin cosmetic that is stable even when stored and can simultaneously exhibit and impart excellent skin roughness prevention effects, skin anti-aging effects, and excellent skin whitening effects.
(従来の技術)
老化した皮膚は柔軟性、弾力性を失い、皮膚のシワが増
大し、乾燥して滑らかさのない荒れ肌で、角質m胞剥離
現象が認められる。(Prior Art) Aging skin loses its flexibility and elasticity, wrinkles increase, the skin becomes dry and rough without smoothness, and a phenomenon of exfoliation of keratin follicles is observed.
最近、皮膚老化防止に関する化粧料が僅かに提案されて
いるが、十分な効果を有するものが見あえらない。Recently, a few cosmetics have been proposed for preventing skin aging, but none have been found to be sufficiently effective.
一方、日焼けし九肌を健常な肌色に回復するには、増加
形成しているメラニン色素の淡色漂白やメラニン生成過
程でのチロシナーゼ活性の阻害等が必要であるとされて
いる。On the other hand, in order to restore sunburned skin to a healthy complexion, it is said that it is necessary to lighten the increasing amount of melanin pigment formed and inhibit tyrosinase activity during the melanin production process.
これらの原理を応用し九美白化粧料の活性物質として、
いくつかのアスコルビン酸誘導体が研究され、アスコル
ビン酸の8−モノ直1m Ill 肪酸エステル、2.
6−ジ直鎖脂肪酸エステル等が提案されている(特公昭
45−16J1G1号、特公昭46−28684号)、
シかしながら、化粧料に応用し穴場合、経日安定性に問
題があったり、変色、変臭の原因となったり、ま九優れ
た美白効果が得られないという欠点がある。Applying these principles, as an active substance for nine whitening cosmetics,
Several ascorbic acid derivatives have been investigated, including the 8-mono-Ill fatty acid ester of ascorbic acid, 2.
6-di straight chain fatty acid esters have been proposed (Japanese Patent Publication No. 45-16 J1G1, Japanese Patent Publication No. 46-28684),
However, when applied to cosmetics, there are drawbacks such as problems with stability over time, discoloration and odor, and the inability to obtain excellent whitening effects.
一方、特公昭44−81287号公報に提案されている
アスコルビン酸のリン酸エステルは、安定性が可成り良
好であるが、化粧料に応用した場合、十分な美白効果を
発現しない。On the other hand, the phosphoric acid ester of ascorbic acid proposed in Japanese Patent Publication No. 44-81287 has fairly good stability, but does not exhibit sufficient whitening effect when applied to cosmetics.
以上の如く肌荒れ防止効果、皮膚の老化防止効果および
美白効果を同時に発現、付与し得る優れた皮膚化粧料は
いまだみられない。As described above, an excellent skin cosmetic that can simultaneously exhibit and provide skin roughness prevention effects, skin anti-aging effects, and skin whitening effects has not yet been found.
(発明が解決しようとする問題点)
本発明の目的は、長期保存しても安定で、変色、変臭、
活性低下等を起こすことなく、使用時には皮膚判激なく
良好な感触を与えながら身体を美化し、魅力を増し、皮
膚をすこやかに保ち、皮膚老化防止効果と美白効果とを
同時に発現、付与し得る優れた皮膚化粧料を提供するこ
とにある。(Problems to be Solved by the Invention) The object of the present invention is to be stable even when stored for a long period of time, and to prevent discoloration and odor.
It beautifies the body, increases attractiveness, keeps the skin healthy, and can simultaneously express and impart skin anti-aging effects and whitening effects without causing a decrease in activity, while giving a good feel without harshness on the skin. Our goal is to provide excellent skin cosmetics.
(問題点を解決するための手段)
本発明の前記目的は、6−〇−高高級アシルアスコルビ
ン酸−2リン酸エステル塩、6−0−高級アシルアスコ
ルビン酸−8−リン酸エステル塩つを含有していること
を特徴とする皮膚化粧料によって達成される。(Means for Solving the Problems) The object of the present invention is to provide 6-0-higher acylascorbic acid-2-phosphate ester salts and 6-0-higher acylascorbic acid-8-phosphate ester salts. This is achieved by a skin cosmetic product characterized by containing.
前記本発明のアスコルビン酸誘導体(6−0−高級アシ
ルアスコルビン酸−リン酸エステル塩)は、6−〇−高
高級アシルアスコルビン酸を二酸化イオウ−トリメチル
アミン錯体、無水硫酸、クロルスルホン酸等と反応(硫
酸エステル化)させるト生成スる6−0−高級アシルア
スコルビン酸−リン酸エステルに、水酸化ナトリウム、
水酸化カリウム、水酸化マグネシウム、水酸化カルシウ
ム、水酸化バリウム、水酸化アンモニウム、モノエタノ
ールアミン、ジェタノールアミン、トリエタノールアミ
ン等の塩基を反応(造塩反応)させることによって得ら
れる。The ascorbic acid derivative (6-0-higher acylascorbic acid phosphate ester salt) of the present invention is obtained by reacting 6-0-higher acylascorbic acid with a sulfur dioxide-trimethylamine complex, sulfuric anhydride, chlorosulfonic acid, etc. To the 6-0-higher acylascorbic acid phosphate ester produced by sulfuric acid esterification, sodium hydroxide,
It is obtained by reacting a base such as potassium hydroxide, magnesium hydroxide, calcium hydroxide, barium hydroxide, ammonium hydroxide, monoethanolamine, jetanolamine, triethanolamine, etc. (salt formation reaction).
本発明における前記の6−〇−高高級アシルアスコルビ
ン酸−リン酸エステル塩しては、例えば、6−0−デカ
ノイルアスコルビン酸−2−リン酸エステル、6−O−
デカノイルアスコルビン酸−8−リン酸エステル、6−
0−ドデカノイルアスコルビン酸−2−リン酸エステル
、6−0−ドデカノイルアスコルビン酸−8−リン酸エ
ステル、6−0−テトラデカノイルアスコルビン酸−2
−リン酸エステル、6−o−テトラデカノイルアスコル
ビン酸−8−リン酸エステル、6−o−ヘキサデカノイ
ルアスコルビン酸−2−リン酸エステル、6−0−ヘキ
サデカノイルアスコルビン酸−8−リン酸エステル、6
−o−オクタデカノイルアスコルビン酸−2−リン酸エ
ステル、6−0−オクタデカノイルアスコルビン酸−8
−リン酸エステル、6−0−エイコサノイルアスコルビ
ン酸−2−リン酸エステル、6−o−エイコサノイルア
スコルビン酸−8−リン酸エステルのナトリウム塩、カ
リウム塩、マグネシウム塩、カルシウム塩、バリウム塩
、アンモニウム塩、モノエタノールアミン塩、ジェタノ
ールアミン塩、トリエタノールアミン塩等が好ましい。The 6-0-higher acylascorbic acid phosphate ester salt in the present invention includes, for example, 6-0-decanoyl ascorbic acid 2-phosphate, 6-O-
Decanoyl ascorbic acid-8-phosphate ester, 6-
0-dodecanoyl ascorbic acid-2-phosphate, 6-0-dodecanoyl ascorbic acid-8-phosphate, 6-0-tetradecanoyl ascorbic acid-2
-phosphoric acid ester, 6-o-tetradecanoyl ascorbic acid-8-phosphoric acid ester, 6-o-hexadecanoyl ascorbic acid-2-phosphoric acid ester, 6-0-hexadecanoyl ascorbic acid-8-phosphoric acid ester acid ester, 6
-o-octadecanoyl ascorbic acid-2-phosphate, 6-0-octadecanoyl ascorbic acid-8
- Phosphate, 6-0-eicosanoyl ascorbic acid-2-phosphate, sodium salt, potassium salt, magnesium salt, calcium salt, barium of 6-o-eicosanoyl ascorbic acid-8-phosphate Preferred are salts, ammonium salts, monoethanolamine salts, jetanolamine salts, triethanolamine salts, and the like.
本発明において、前記本発明のアスコルビン酸誘導体は
各々単独で、もしくは2種以上の混合物として皮膚化粧
料基剤に配合される。その配合量は、皮膚化粧料の形態
(種類)によって異なるけれども、総括的な配合量は、
当該化粧料の処方成分全量を基準として(以下同様)、
通常0.06〜20重量%の範囲内である。In the present invention, each of the ascorbic acid derivatives of the present invention is incorporated into a skin cosmetic base either alone or as a mixture of two or more. Although its amount varies depending on the form (type) of skin cosmetics, the overall amount is as follows:
Based on the total amount of prescription ingredients of the cosmetic concerned (the same applies hereinafter),
It is usually within the range of 0.06 to 20% by weight.
更に具体的な配合量の範囲を記すと、クリーム状(乳化
型)化粧料では0.05〜10重社%(好ましくは1〜
5重量%)、乳液状化粧料では0.05〜10重量%(
好ましくは1〜5重量%)、水性透明液状の化粧料では
0.05〜2.0重量%(好ましくはo、 i〜1.0
重量%)、油状化粧料では0.05〜20重量%(好ま
しくは1〜15重量%)、ケーキ状化粧料では0.06
〜17重麓%(好ましくは8〜10重量%)、粉末状化
粧料では1〜20重量%(好ましくは5〜15重量%)
、パック剤では0.1〜8重量%(好ましくは0.6〜
2重量%)である。More specifically, the blending amount range is 0.05 to 10% (preferably 1 to 1%) for creamy (emulsified) cosmetics.
5% by weight), and 0.05-10% by weight for emulsion cosmetics (
Preferably 1 to 5% by weight), and 0.05 to 2.0% by weight for aqueous transparent liquid cosmetics (preferably o, i to 1.0% by weight).
weight%), 0.05 to 20% by weight (preferably 1 to 15% by weight) for oily cosmetics, and 0.06% for cake-like cosmetics.
~17% by weight (preferably 8-10% by weight), 1-20% by weight (preferably 5-15% by weight) for powdered cosmetics
, 0.1 to 8% by weight in pack agents (preferably 0.6 to 8% by weight)
2% by weight).
本発明のクリーム状または乳液状の化粧料は、例えばマ
ツサージクリーム、クレンジングクリーム、スキンクリ
ーム、ファンデージ■ンクリーム、ミルキーローシ■ン
等の公知のクリーム状ま九は乳液状の皮膚化粧料の基剤
に、前記の本発明のアスコルビン酸誘導体を前記所要量
配合することによって得られる。その配合方法は公知の
方法を採用し得る。The cream or emulsion cosmetic of the present invention is a base of known cream or emulsion skin cosmetics such as pine surge cream, cleansing cream, skin cream, foundation cream, and milky lotion. The ascorbic acid derivative of the present invention is blended into the agent in the required amount. A known method can be used for the blending method.
前記化粧料の基剤に使用し得る基材の乳化剤としては、
例えば通常の非イオン杢界面活性剤、アニオン型界面活
性剤、両性型界面活性剤等の合成乳化剤や、レシチン、
シ!!糖脂肪酸エステル、高級アシルグルタミン酸塩、
ペクチン、カラヤガム、ローカストビーンガム、グリチ
ルリチン(18α一体、または18β一体)酸またはそ
のアルカリ金IA4、アンモニウム塩、水溶性コラーゲ
ン(ポリペプチド)等の天然物系の界面活性物質や、ナ
トリウム型ベントナイト等の公知の乳化剤が挙げられる
。乳化剤の配合量は処方成分全量に対して通常0.05
〜5重量%の範囲内である。Base emulsifiers that can be used in the base of the cosmetic include:
For example, synthetic emulsifiers such as ordinary nonionic surfactants, anionic surfactants, amphoteric surfactants, lecithin,
Shi! ! Sugar fatty acid ester, higher acyl glutamate,
Natural surfactants such as pectin, karaya gum, locust bean gum, glycyrrhizin (18α monolithic or 18β monolithic) acid or its alkali gold IA4, ammonium salts, water-soluble collagen (polypeptide), sodium bentonite, etc. Known emulsifiers may be mentioned. The amount of emulsifier added is usually 0.05% of the total amount of prescription ingredients.
-5% by weight.
また、基材の油性物質としては、皮膚化粧料用の油性物
質であって、例えば植物油、動物油、高級脂肪酸、高級
アルコール、合成エステル油、ワックス類、シリコン油
等が挙げられる。In addition, the oily substance for the base material is an oily substance for skin cosmetics, such as vegetable oil, animal oil, higher fatty acid, higher alcohol, synthetic ester oil, waxes, silicone oil, and the like.
このような基材としての油性物質の配合量は。What is the blending amount of such an oily substance as a base material?
処方成分全量に対して通常5〜60重量%である。It is usually 5 to 60% by weight based on the total amount of prescription ingredients.
配合し得る他の成分としては、香料、防腐剤、顔料等の
他、必要に応じて皮膚栄養剤、保湿剤、紫外線防止剤、
pH調整剤を適用し得る。Other ingredients that may be blended include fragrances, preservatives, pigments, etc., as well as skin nutrients, moisturizers, UV inhibitors,
pH adjusting agents may be applied.
前記の本発明のアスコルビン酸誘導体は、安定性、油性
基剤との相溶性、乳化性等が良い故、乳化型化粧料の処
方設計が容易であり、しかも皮膚老化防止効果、美白効
果、乳化安定性、保存安定性、粘度(硬度)安定性、外
観(肌目、光沢)、使用時の伸び及び感触等の良好な製
品を容易に得ることができる。The ascorbic acid derivative of the present invention has good stability, compatibility with oily bases, emulsifying properties, etc., so it is easy to design formulations for emulsifying cosmetics, and it also has anti-aging effects, whitening effects, and emulsifying properties. Products with good stability, storage stability, viscosity (hardness) stability, appearance (texture, gloss), spreadability and feel during use can be easily obtained.
本発明の水性透明液状の化粧料は、通常のローシーン類
や皮膜型パック剤等の基剤に前記本発明のアスコルビン
酸誘導体を所要量配合することによって得られる。この
場合、前記本発明のアスコルビン酸誘導体は、水や水−
アルコール系の中に可溶化しやすく、ま次女定性が高い
故に処方設計が極めて容易で、しかも皮膚老化防止効果
及び美白効果を安定に保持し次透明ローシーンや透明な
皮膜型美白パック剤を容易に得ることかできる。The aqueous transparent liquid cosmetic composition of the present invention can be obtained by blending a required amount of the ascorbic acid derivative of the present invention into a base such as a usual skin care product or a film-type pack agent. In this case, the ascorbic acid derivative of the present invention may contain water or water-
Because it is easily solubilized in alcohol and has high secondary properties, it is extremely easy to design formulations, and it stably maintains skin anti-aging and whitening effects, making it easy to create transparent low-scene and transparent film-type whitening packs. You can get it.
水性透明液状の美白化粧料基剤には、エタノールや皮膜
剤等の慣用基剤の他に、香料、着色剤、防腐剤や、必要
に応じて皮膚栄養剤、保湿剤、pH1JiIi剤等を配
合し得る。In addition to conventional bases such as ethanol and film agents, the aqueous transparent liquid whitening cosmetic base contains fragrances, colorants, preservatives, and if necessary, skin nutrients, moisturizers, pH1JII agents, etc. It is possible.
本発明の油状美白化粧料は、後記の如き液状の油性基材
に、前記の本発明のアスコルビン酸誘導体の適当量を添
加し、均一溶解することにより得られる。その液状の油
性基材としては、例えば、アーモンド油、オリーブ油、
ゴマ油、サフラワー油、ミンク油、アボカド油、ホホバ
油、イソプロピルパルミテート、イソプロピルミリステ
ート、オレイルアルコール、イソステアリルアルコール
、オクチルドデカノール等を挙げることができる。The oily whitening cosmetic composition of the present invention can be obtained by adding an appropriate amount of the ascorbic acid derivative of the present invention to a liquid oily base material as described below and uniformly dissolving it. Examples of the liquid oil base include almond oil, olive oil,
Examples include sesame oil, safflower oil, mink oil, avocado oil, jojoba oil, isopropyl palmitate, isopropyl myristate, oleyl alcohol, isostearyl alcohol, octyldodecanol, and the like.
これらの中で皮脂に易溶な油性物質は特に好ましい。Among these, oily substances that are easily soluble in sebum are particularly preferred.
本発明の油状美白化粧料は、実質的に透明な流動性の高
いオイル状を呈し、かつ非水系を形成している。そして
前記本発明のアスコルビン酸誘導体は既述の如(溶解性
、安定性に優れているのでその液状油性基剤の中に完全
に溶解しており、長期保存しても活性低下を生起するこ
となく、良好な皮膚老化防止効果及び美白効果を発揮す
ることができる。The oily whitening cosmetic composition of the present invention has a substantially transparent highly fluid oily state and is non-aqueous. As mentioned above, the ascorbic acid derivative of the present invention has excellent solubility and stability, so it is completely dissolved in the liquid oily base, and does not cause a decrease in activity even after long-term storage. However, it can exhibit good skin anti-aging effects and whitening effects.
本発明におけるケーキ状の化粧料は、主要構成成分とし
て顔料と、前記本発明のアスコルビン酸誘導体、または
通常の化粧料用油性物質とを使用して公知のプロセスに
よって製造される。The cake-like cosmetic composition of the present invention is produced by a known process using a pigment as the main constituents and the ascorbic acid derivative of the present invention or a conventional oily substance for cosmetics.
本発明の粉末状の美白化粧料は、デンプン、乳糖、マン
ニット、沈降炭酸カルシウム等の慣用粉末基材に、本発
明のアスコルビン酸誘導体を添加し、均一に混練するこ
とによって製造される。The powdered whitening cosmetic of the present invention is produced by adding the ascorbic acid derivative of the present invention to a conventional powder base material such as starch, lactose, mannitol, precipitated calcium carbonate, etc., and uniformly kneading the mixture.
(作用)
本発明におけるアスコルビン酸誘導体は、適度な親水性
と親油性を有し、化粧料の系中での安定性、化粧料基材
との相溶性、乳化性、人体に対する安全性が高く良好で
あるので、皮膚化粧料の処方設計が容易となり、そして
経日安定性が良好で、皮膚1激なくフィーリングの良い
良好な感触を与える化粧料を提供することがてきる。(Function) The ascorbic acid derivative in the present invention has appropriate hydrophilicity and lipophilicity, and has high stability in cosmetic systems, compatibility with cosmetic base materials, emulsifying properties, and safety for the human body. This makes it easy to design formulations for skin cosmetics, and it is possible to provide cosmetics that have good stability over time and give a good feeling without causing irritation to the skin.
本発明の皮膚化粧料を皮膚に塗市すると前記本発明のア
スコルビン酸誘導体は速やかに皮脂中に溶解、拡散して
容易に皮脂に浸透して、皮膚組織の活性および代謝を促
進し、その結果、前記の皮膚老化防止効果を発現すると
共に、皮膚組織中のチロシナーゼの活性を適度良好に阻
害し優れた皮膚の美白効果を発現し得る。When the skin cosmetic of the present invention is applied to the skin, the ascorbic acid derivative of the present invention quickly dissolves and diffuses into the sebum and easily penetrates the sebum, promoting the activity and metabolism of the skin tissue, and as a result. In addition to exhibiting the above-mentioned skin aging prevention effect, it can inhibit the activity of tyrosinase in skin tissues to a moderate degree and exhibit an excellent skin whitening effect.
(!l!施例) 以下、本発明を実施例によって、更に詳細に説明する。(!l!Example) Hereinafter, the present invention will be explained in more detail with reference to Examples.
尚、実施例に示す部とは重量部、%とは重量%である。In addition, parts shown in Examples are parts by weight, and % is weight %.
また、荒れ肌改善効果、角質改善効果、官能効果、美白
効果、保存安定性等の試験法は下記の通りである。Test methods for improving rough skin, keratin improving effect, sensory effect, whitening effect, storage stability, etc. are as follows.
(1) 荒れ肌改善効果の測定試験法下脚に荒れ肌を
有する中高年被験者20名を対象として4j¥I間連続
塗布効果を調べた。被験者の左側下脚試験部位に1日2
回約1!iの化粧料サンプルを塗布し、試験開始前およ
び終了後の皮膚の状態を第1表の基準により判定し九。(1) Test method for measuring the effect of improving rough skin The effect of continuous application over 4J\I was investigated on 20 middle-aged and elderly subjects who had rough skin on their lower legs. 2 per day to the subject's left lower leg test site.
About 1 time! Apply the cosmetic sample (i) and judge the condition of the skin before and after the test according to the criteria in Table 1.9.
右側下脚は試料を塗布せず対照とし九。No sample was applied to the right lower leg and it was used as a control.
第1表 皮膚乾燥度の判定基準
m:正常
±:軽微乾燥、落屑なし
+:乾燥、落屑軽度
++:乾燥、落屑中程度
+++:乾燥、落屑顕著
試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば+→−1
++→±)を「有効」、1段階改善された場合を「やや
有効」、変化がなかった場合を「無効」とした。尚、試
験期間中に皮膚の乾燥が進んだ例はなかった。Table 1 Judgment criteria for skin dryness m: Normal ±: Slight dryness, no flaking +: Slight dryness, flaking ++: Moderate dryness, flaking +++: Significant dryness, flaking Judgment results of the test site and control site before and after the test If the skin dryness has improved by two or more levels (e.g. +→-1)
++→±) was considered "effective," one level of improvement was considered "slightly effective," and no change was considered "ineffective." There were no cases of skin dryness progressing during the test period.
(2) 角質改善(角質細胞の抗剥離性増大)効果の
測定試験法
前述の荒れ肌改善測定試験開始前詔よび終了後の被験部
皮膚にスコッチテープにチバンメンディングテープ)を
接着し、これを剥離した時テープに付着した角質細胞の
状態を走査型電子顕微鏡によって詳細に調べ、第2表の
基準によって皮膚角質細胞抗剥離性を分離し、角質改善
効果を求めた。(2) Test method for measuring the effect of improving keratin (increasing the anti-exfoliation properties of keratinocytes) A Scotch tape (Tiban mending tape) was adhered to the test area skin before and after the start of the rough skin improvement measurement test described above. The condition of the keratinocytes that adhered to the tape when it was peeled off was examined in detail using a scanning electron microscope, and the anti-removal properties of skin keratinocytes were determined according to the criteria shown in Table 2, and the keratin improving effect was determined.
第2表 角質改善効果(角質細胞抗剥離性増大)の判定
基準
評価点1ニスケール認めず
# 2:小スケール点在
# 8:小物中スケール顕著
l 4:大スケール顕著
第2表は4週間連続塗布後の試験部位の評価点と対照部
位のそれとの差が2点以上の場合を「有効」、1点の場
合を「やや有効」、0点の場合を「無効」とした。Table 2 Judgment criteria for keratin improvement effect (increased anti-desquamation property of keratinocytes) Evaluation points 1 Two scales not observed # 2: Small scales dotted # 8: Small scales are noticeable 4: Large scales are noticeable Table 2 shows 4 consecutive weeks When the difference between the evaluation score of the test site after application and that of the control site was 2 or more points, it was considered "effective," when it was 1 point, "somewhat effective," and when it was 0 points, "ineffective."
尚、試験部位の評価点が対照部位のそれよりも大きい例
はなかつ友。In addition, there are no cases where the evaluation score of the test site is higher than that of the control site.
なお、この角質細胞の剥離特性は、角質層の構造特性を
判断する指標となるものであって、一般に乾燥皮膚、老
化皮膚に於ては、細胞間結合量が弱く、またその構造の
緻密性も低いことから指数が高くなることが確認されて
いる。The exfoliation properties of these corneocytes serve as an index for determining the structural properties of the stratum corneum, and in general, in dry skin and aging skin, the amount of intercellular bonds is weak and the density of the structure is poor. It has been confirmed that the index is high because the index is also low.
(3) 官能効果のパネルテスト
8 (lt7)中年(80〜60才)女子パネラ−の顔
面に試料を1日2回、2ケ月間連続塗布し、パネラ一本
人が試験開始前および終了後の皮膚の状態を、「しわ伸
ばし効果」、「はりに対する効果上「しっとり感に対す
る効果」につきそれぞれ評価した。(3) Sensory effect panel test 8 (lt7) A sample was applied to the face of a middle-aged (80-60 years old) female panelist twice a day for two months, and each panelist tested the test before and after the test. The condition of the skin was evaluated for ``wrinkle smoothing effect,'' ``effect on firmness, and ``effect on moisturizing feeling.''
(4) 美白効果のパネルテスト
色黒、シミ、ソバカスに悩む被験者(女子)20名のパ
ネラ−に試料を毎日朝、ター回2ケ月塗布し、「有効」
、「やや有効」または「無効」のいずれかをパネラ一本
人が判定しな。(4) Panel test of skin whitening effect The sample was applied to a panel of 20 female subjects suffering from dark skin, age spots, and freckles every morning for two months, and was found to be effective.
, Panela itself will judge whether it is ``slightly effective'' or ``ineffective.''
(5) 保存安定性試験(40℃、6ケ月後の化粧料
の安定性)
化粧料の試料を40℃の恒温室に6ケ月間保存した後の
外観変化(分離、着色の有無等)、変臭の有無等を専凹
検査員8人によってしらべ九。(5) Storage stability test (stability of cosmetics after 6 months at 40°C) Changes in appearance (presence or absence of separation, coloring, etc.) of cosmetics samples after storing them in a constant temperature room at 40°C for 6 months, Eight specialized concave inspectors inspected the containers for the presence or absence of strange odors.
実施例1
処方
東■6−0−ヘキサデカノイルアスコルビン酸−2−リ
ン酸エステルマグネシウム塩4.0部■スクワラン
25.0■マイクロクリスタリンワ
ツクス 5.00オリーブ油
a、O■キサンタンガム
1.0■グリチルリチン酸モノアンモニウム
0.80メチルパラベン
0.2■精製水 61
.5■香 料 適 量上記
処方にて、常法によりO/W型エマルジ目ンのクリーム
状化粧料を得た。この化粧料の試験結果は後記第8表に
示した。Example 1 Prescription ■ 4.0 parts of 6-0-hexadecanoyl ascorbic acid-2-phosphate magnesium salt ■ Squalane
25.0 ■Microcrystalline wax 5.00 Olive oil
a, O■xanthan gum
1.0 ■ Monoammonium glycyrrhizinate
0.80 Methylparaben
0.2 ■ Purified water 61
.. 5. Perfume Appropriate amount A cream cosmetic in the form of an O/W emulsion was obtained using the above formulation in a conventional manner. The test results for this cosmetic are shown in Table 8 below.
夏 成分■の化合物の構造式は下記の通りである。The structural formula of the compound of summer component (■) is as follows.
比較例1
6−0−ヘキサデカノイルアスコルビン酸−2−リン酸
エステルマグネシウム塩の代りに、アスコルビン酸−2
−リン酸エステルマグネシウム塩を使用する他は、実施
例1と同様に行なって比較のクリーム状化粧料を得た。Comparative Example 1 Ascorbic acid-2 instead of 6-0-hexadecanoyl ascorbic acid-2-phosphate magnesium salt
-A comparative cream cosmetic was obtained in the same manner as in Example 1, except that the magnesium phosphate ester salt was used.
この化粧料の試験結果は後記第8表に示した。The test results for this cosmetic are shown in Table 8 below.
比較例2
6−0−ヘキサデカノイルアスコルビン酸−2−リン酸
エステルマグネシウム塩の代りに、5,6−0−イソプ
ロピリデンアスコルビン酸−2−リン酸エステルマグネ
シウム塩を使用する他は、実施例1と同様に行なって比
較のクリーム状化粧料を得た。この化粧料の試験結果は
後り第8表に示g48表
実施例2
6−0−ヘキサデカノイルアスコルビン酸−2−リン酸
エステルマグネシウム塩の代りに、6−〇−テトラデカ
ノイルアスコルビン酸−8−リン酸エステル七ノエタノ
ールアミン塩を使用する他は、実施例1と同様に行なっ
てクリーム状化粧料を得た。Comparative Example 2 Example 2 except that 5,6-0-isopropylidene ascorbic acid-2-phosphate magnesium salt was used instead of 6-0-hexadecanoyl ascorbic acid-2-phosphate magnesium salt. A comparative creamy cosmetic was obtained in the same manner as in Example 1. The test results of this cosmetic are shown in Table 8 below. Table 48 Example 2 6-0-hexadecanoyl ascorbic acid-2-phosphate ester magnesium salt was replaced with 6-0-tetradecanoyl ascorbic acid-2-phosphate. A cream cosmetic was obtained in the same manner as in Example 1, except that 8-phosphoric acid ester heptanoethanolamine salt was used.
得られたクリーム状化粧料の40℃、6ケ月後の安定性
は、着色、変臭等が無く良好であった。The stability of the obtained creamy cosmetic after 6 months at 40°C was good, with no coloration or odor.
また、しわ伸ばし効果、はりに対する効果、美白効果等
の官能テストの成績も同様に良好であった。In addition, the results of sensory tests such as wrinkle smoothing effect, firmness effect, and whitening effect were similarly good.
実施例8
6−0−ヘキサデカノイルアスコルビン酸−2−リン酸
エステルマグネシウム塩の代りに、下記の構造 6−0
−デカノイルアスコルビン酸−2−リン酸エステル七ノ
ナトリウム塩[株]を使用する他は、実施例1と同様に
行なってクリーム状化粧料を得た。Example 8 Instead of 6-0-hexadecanoyl ascorbic acid-2-phosphate magnesium salt, the following structure 6-0
A cream cosmetic was obtained in the same manner as in Example 1, except that -decanoyl ascorbic acid-2-phosphate heptanosodium salt [Co., Ltd.] was used.
得られたクリーム状化粧料の40℃、6ケ月後の安定性
は、着色、変臭等が無く良好であった。The stability of the obtained creamy cosmetic after 6 months at 40°C was good, with no coloration or odor.
ま次、シわ伸ばし効果、はりに対する効果、美白効果等
の官能テストの成績も同様に良好であった。The results of sensory tests such as eyelids, wrinkle smoothing effect, firmness effect, and whitening effect were similarly good.
[相]
ON!
HO−P=0
実施例4
6−0−ヘキサデカノイルアスコルビン酸−2−リン酸
エステルマグネシウム塩の代りに、6−〇−オクタデカ
ノイルアスコルビン酸−2−リン酸エステルトリエタノ
ールアミン塩を使用する他は、実施例1と同様に行なっ
てクリーム状化粧料を得た。[Phase] ON! HO-P=0 Example 4 6-0-octadecanoyl ascorbic acid-2-phosphate triethanolamine salt is used instead of 6-0-hexadecanoyl ascorbic acid-2-phosphate magnesium salt A cream cosmetic was obtained in the same manner as in Example 1 except for the following steps.
得られたクリーム状化粧料の40℃、6ケ月後の安定性
は、着色、変臭等が無く良好であった。The stability of the obtained creamy cosmetic after 6 months at 40°C was good, with no coloration or odor.
また、しわ伸ばし効果、はりに対する効果、美白効果等
の官能テストの成績も同様に良好であった。In addition, the results of sensory tests such as wrinkle smoothing effect, firmness effect, and whitening effect were similarly good.
実施例6
6−0−ヘキサデカノイルアスコルビン酸−2−リン酸
エステルマグネシウム塩の代りに、6−〇−ヘキサデカ
ノイルアスコルビン酸−2−リン酸エステルジカリウム
塩を使用する他は、実施例1と同様に行なってクリーム
状化粧料を得た。Example 6 Example 1 except that 6-0-hexadecanoyl ascorbic acid-2-phosphate dipotassium salt was used instead of 6-0-hexadecanoyl ascorbic acid-2-phosphate magnesium salt. A creamy cosmetic was obtained in the same manner as above.
得られ九クリーム状化粧料の40℃、6ケ月後の安定性
は、着色、変臭等が無く良好であった。The stability of the obtained nine creamy cosmetics after 6 months at 40°C was good with no discoloration or odor.
また、しわ伸ばし効果、はりに対する効果、美白効果等
の官能テストの成績も同様に良好であった。In addition, the results of sensory tests such as wrinkle smoothing effect, firmness effect, and whitening effect were similarly good.
実施例6
6−0−ヘキサデカノイルアスコルビン酸−2−リン酸
エステルマグネシウム塩の代りに、6−〇−オクタデカ
ノイルアスコルビン酸−2−リン酸エステルジナトリウ
ム塩を使用する他は、実施例1と同様に行なってクリー
ム状化粧料を得た。Example 6 Example 6 except that 6-0-octadecanoyl ascorbic acid 2-phosphate disodium salt was used instead of 6-0-hexadecanoyl ascorbic acid 2-phosphate magnesium salt. A creamy cosmetic was obtained in the same manner as in 1.
得られたクリーム状化粧料の40℃、6ケ月後の安定性
は、着色、変臭等が無く良好であった。The stability of the obtained creamy cosmetic after 6 months at 40°C was good, with no coloration or odor.
まえ、しわ伸ばし効果、はりに対する効果、美白効果等
の官能テストの成績も同様番ζ良好であった。In addition, the results of sensory tests such as wrinkle smoothing effect, firmness effect, whitening effect, etc. were also good.
実施例7
■6−0−ドデカノイルアスコルビン酸−2−リン酸エ
ステルマグネシウム塩 4.0部■ステ
アリン酸 2.5■流動パラフイ
ン 6.00ベヘニルアルコール
0.9■ワセリン
0.6■モノラウリン酸ソルビタン 0.5
0七ノステアリン酸ポリオキシエチレンソルビタン(2
0E、O,) 0・5■グリセリン
8.0■N−アシルグルタミン
酸ナトリウム 0.7[相]メチルパラベン
0.2@精製水 8
8.20査 料 適 愈上記処方
暴ζて、常法によりO/W型エマルジ■ンの乳液状化粧
料を得た。この化粧料の試験結果は′”″“′″°′°
い1・h・)1、灸1.l
!4表
実施例8
6−0−)’デカノイルアスコルビン酸−2−リン酸エ
ステルマグネシウム塩の代りに、6−0−オクタデカノ
イルアスコルビン酸−2−リン酸エステルマグネシウム
塩を使用する他は、実施例7と同様に行なって乳液状化
粧料を得皮。Example 7 ■ 6-0-Dodecanoyl ascorbic acid-2-phosphate magnesium salt 4.0 parts ■ Stearic acid 2.5 ■ Liquid paraffin 6.00 Behenyl alcohol
0.9■Vaseline
0.6 ■ Sorbitan monolaurate 0.5
07nostearate polyoxyethylene sorbitan (2
0E, O,) 0.5 ■ Glycerin 8.0 ■ Sodium N-acylglutamate 0.7 [Phase] Methyl paraben
0.2@purified water 8
8.20 Examination Applicability By using the above formulation, a milky lotion cosmetic of an O/W type emulsion was obtained by a conventional method. The test results for this cosmetic are ′”″“′″°′°
i1・h・)1, Moxibustion1. l! Table 4 Example 8 6-0-)' 6-0-octadecanoyl ascorbic acid-2-phosphate magnesium salt was used instead of decanoyl ascorbic acid-2-phosphate magnesium salt. A milky lotion cosmetic was obtained in the same manner as in Example 7.
得られ友乳液状化粧料の40℃、6ケ月後の安定性は、
着色、変臭等が郁く良好であう几。また、しわ伸ばし効
果、はりに対する効果、美白効果等の官能テストの成績
も同様に良好であつな。The stability of the obtained liquid cosmetic after 6 months at 40°C is as follows:
A container that is much better against coloring, odor, etc. In addition, the results of sensory tests such as wrinkle smoothing effect, firmness effect, and whitening effect were also good.
実施例9
6−0−ドデカノイルアスコルビン酸−2−リン酸エス
テルモノエタノールアミン塩の代りに。Example 9 6-0-dodecanoyl ascorbic acid-2-phosphate instead of monoethanolamine salt.
6−0−オクタデカノイルアスコルビン酸−2−リン酸
エステルモノカリウム塩を使用する他は、実施例5と同
様に行なって乳液状化粧料を得念。A milky lotion cosmetic was prepared in the same manner as in Example 5, except that 6-0-octadecanoyl ascorbic acid-2-phosphate monopotassium salt was used.
?埠られ念乳液状化粧料の40℃、6ケ月後の安定性は
、着色、変臭等が無く良好であった。また、しわ伸ばし
効果、はりに対する効果、美白効果等の官能テストの成
后も同様に良好であった。? The stability of the emulsion cosmetic after 6 months at 40°C was good with no discoloration or odor. In addition, the results of sensory tests such as wrinkle smoothing effect, firmness effect, and whitening effect were similarly good.
実施例10
6−0−デカノイルアスコルビンミーミーリン酸エステ
ルバリウム塩0.7部、6−〇−エイコサノイルアスコ
ルビンa2−2−リン酸エステルアンモニウム塩0.7
部、エタノール18部、グリセリンS部、ポリオキシエ
チレン硬化ヒマシ油2部。Example 10 0.7 parts of 6-0-decanoyl ascorbic acid ester barium salt, 0.7 parts of 6-0-eicosanoyl ascorbic acid ester ammonium salt
1 part ethanol, 1 part glycerin S, 2 parts polyoxyethylene hydrogenated castor oil.
fitu水71.6部およびポリビニルアルコール9部
の処方(組成)からなる本発明のパック剤を常法により
餉製した。得られたパック剤の40℃、6ケ月後の安定
性は着色、変臭等が鮒く良好であった。またしわ伸ばし
効果、はりに対する効果、しっとり感に対する効果、美
白効果等の官能テストの成績も良好であり次。A pack agent of the present invention having a formulation (composition) of 71.6 parts of water and 9 parts of polyvinyl alcohol was prepared by a conventional method. The stability of the obtained pack agent after 6 months at 40°C was good, with no discoloration, odor, etc. It also has good results in sensory tests such as wrinkle smoothing effect, firmness effect, moisturizing effect, and whitening effect.
実施例11
6−0−テトラデカノイルアスコルビン酸−8−リン酸
エステルカルシウム塩12部、デンプン80部、乳糖5
5部および香料適量を均一に混合して、本発明の粉末状
化粧料を得几。Example 11 12 parts of 6-0-tetradecanoyl ascorbic acid-8-phosphate calcium salt, 80 parts of starch, 5 parts of lactose
5 parts and an appropriate amount of perfume were mixed uniformly to obtain the powdered cosmetic of the present invention.
この粉末状化粧料を10倍量の乳液中に均一に混練して
、これを顔面に塗布した。1日2回2ケ月間連用した時
の、しわ伸ばし効果、はりに対する効果、しっとり感に
対する効果、美白効果等の官能テストも良好であっ次。This powdered cosmetic was uniformly kneaded into a 10-fold amount of emulsion and applied to the face. When used twice a day for two months, sensory tests such as wrinkle smoothing effect, firmness effect, moisturizing effect, whitening effect, etc. were also positive.
Claims (1)
ル塩、6−0−高級アシルアスコルビン酸−3−リン酸
エステル塩からなる群より選択された6−0−高級アシ
ルアスコルビン酸−リン酸エステル塩の少なくとも一つ
を含有していることを特徴とする皮膚化粧料。6-0-higher acylascorbic acid-phosphate ester selected from the group consisting of 6-0-higher acylascorbic acid-2-phosphate ester salt and 6-0-higher acylascorbic acid-3-phosphate ester salt A skin cosmetic containing at least one salt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27941484A JPS61152613A (en) | 1984-12-26 | 1984-12-26 | Skin cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27941484A JPS61152613A (en) | 1984-12-26 | 1984-12-26 | Skin cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61152613A true JPS61152613A (en) | 1986-07-11 |
JPH0528686B2 JPH0528686B2 (en) | 1993-04-27 |
Family
ID=17610757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP27941484A Granted JPS61152613A (en) | 1984-12-26 | 1984-12-26 | Skin cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61152613A (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5376361A (en) * | 1993-01-13 | 1994-12-27 | Perricone; Nicholas V. | Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage |
US5409693A (en) * | 1989-10-12 | 1995-04-25 | Perricone; Nicholas V. | Method for treating and preventing sunburn and sunburn damage to the skin |
FR2715565A1 (en) * | 1994-01-31 | 1995-08-04 | Oreal | Stabilized cosmetic or dermatological composition containing several precursors of the same active ingredient to maximize its release, its use. |
EP0875514A1 (en) * | 1997-04-30 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Ascorbic acid derivative and vitamin C preparation containing the same |
US6110966A (en) * | 1998-02-20 | 2000-08-29 | Medi-Cell Laboratories, Inc. | Triple action complex |
JP2002167319A (en) * | 2000-09-22 | 2002-06-11 | Asahi Kasei Corp | Bleaching cosmetic |
EP1077066A4 (en) * | 1998-05-15 | 2005-06-29 | Showa Denko Kk | Preventives/remedies for skin diseases |
JP2005187465A (en) * | 2003-12-04 | 2005-07-14 | Showa Denko Kk | Emulsified skin care preparation for external use containing salt of higher fatty acid ester of ascorbic acid-2-phosphoric acid ester, method for producing the same, and method for stabilizing the salt of ester |
CN1297266C (en) * | 2002-04-12 | 2007-01-31 | 昭和电工株式会社 | Stabilized ascorbic acid derivatives |
JP2007320858A (en) * | 2006-05-30 | 2007-12-13 | Nippon Menaade Keshohin Kk | Composition containing ascorbic acid 2-phosphate derivative |
JP2012001457A (en) * | 2010-06-15 | 2012-01-05 | Toyo Beauty Kk | Anti-wrinkle agent and anti-aging cosmetic |
WO2014097721A1 (en) * | 2012-12-20 | 2014-06-26 | 昭和電工株式会社 | Ascorbic acid derivative composition and method for producing same, ascorbic acid derivative solution, and external preparation for skin |
WO2014104171A1 (en) | 2012-12-27 | 2014-07-03 | 株式会社林原 | Skin-exterior anti-ageing composition and production method therefor |
WO2020226147A1 (en) | 2019-05-07 | 2020-11-12 | 株式会社林原 | Gel-type external composition for skin |
-
1984
- 1984-12-26 JP JP27941484A patent/JPS61152613A/en active Granted
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5409693A (en) * | 1989-10-12 | 1995-04-25 | Perricone; Nicholas V. | Method for treating and preventing sunburn and sunburn damage to the skin |
US5376361A (en) * | 1993-01-13 | 1994-12-27 | Perricone; Nicholas V. | Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage |
FR2715565A1 (en) * | 1994-01-31 | 1995-08-04 | Oreal | Stabilized cosmetic or dermatological composition containing several precursors of the same active ingredient to maximize its release, its use. |
EP0667145A1 (en) * | 1994-01-31 | 1995-08-16 | L'oreal | Stabilized cosmetic or dermatologic composition containing several precursors of a same active agent |
US5607921A (en) * | 1994-01-31 | 1997-03-04 | L'oreal | Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof |
EP0875514A1 (en) * | 1997-04-30 | 1998-11-04 | Showa Denko Kabushiki Kaisha | Ascorbic acid derivative and vitamin C preparation containing the same |
US6110966A (en) * | 1998-02-20 | 2000-08-29 | Medi-Cell Laboratories, Inc. | Triple action complex |
EP1077066A4 (en) * | 1998-05-15 | 2005-06-29 | Showa Denko Kk | Preventives/remedies for skin diseases |
JP2002167319A (en) * | 2000-09-22 | 2002-06-11 | Asahi Kasei Corp | Bleaching cosmetic |
CN1297266C (en) * | 2002-04-12 | 2007-01-31 | 昭和电工株式会社 | Stabilized ascorbic acid derivatives |
JP2005187465A (en) * | 2003-12-04 | 2005-07-14 | Showa Denko Kk | Emulsified skin care preparation for external use containing salt of higher fatty acid ester of ascorbic acid-2-phosphoric acid ester, method for producing the same, and method for stabilizing the salt of ester |
JP2007320858A (en) * | 2006-05-30 | 2007-12-13 | Nippon Menaade Keshohin Kk | Composition containing ascorbic acid 2-phosphate derivative |
JP2012001457A (en) * | 2010-06-15 | 2012-01-05 | Toyo Beauty Kk | Anti-wrinkle agent and anti-aging cosmetic |
WO2014097721A1 (en) * | 2012-12-20 | 2014-06-26 | 昭和電工株式会社 | Ascorbic acid derivative composition and method for producing same, ascorbic acid derivative solution, and external preparation for skin |
US9351915B2 (en) | 2012-12-20 | 2016-05-31 | Showa Denko K.K. | Ascorbic acid derivative composition and production method of the same, ascorbic acid derivative solution, and skin external preparation |
JPWO2014097721A1 (en) * | 2012-12-20 | 2017-01-12 | 昭和電工株式会社 | Ascorbic acid derivative composition and method for producing the same, ascorbic acid derivative solution, and external preparation for skin |
WO2014104171A1 (en) | 2012-12-27 | 2014-07-03 | 株式会社林原 | Skin-exterior anti-ageing composition and production method therefor |
US10111822B2 (en) | 2012-12-27 | 2018-10-30 | Hayashibara Co., Ltd. | External dermal composition for anti-ageing and method for producing the same |
EP3398585A1 (en) | 2012-12-27 | 2018-11-07 | Hayashibara Co., Ltd. | External dermal composition for anti-ageing and method for producing the same |
WO2020226147A1 (en) | 2019-05-07 | 2020-11-12 | 株式会社林原 | Gel-type external composition for skin |
Also Published As
Publication number | Publication date |
---|---|
JPH0528686B2 (en) | 1993-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100318355B1 (en) | New Cosmetic and Dermatological Compositions Combining Ceramide and Linoleic Acid | |
US5885593A (en) | Skin care composition including cyclodextrin materials and method for treating skin therewith | |
JP2000119127A (en) | Cosmetic and/or dermatological composition containing at least one extract of mulberry, at least one extract of skull cap and at least one salicylic acid derivative | |
JPH08283144A (en) | Cosmetic and/or dermatological composition containing salicylic acid derivative for decoloring of skin | |
JP2886591B2 (en) | Cosmetics | |
JPS61152613A (en) | Skin cosmetic | |
JPS59219209A (en) | Skin cosmetic | |
JP2001288032A (en) | Active oxygen-eliminating agent and skin cosmetic for preventing aging | |
JP3001834B2 (en) | Depigmenting agent comprising N, N'-dibenzylethylenediamine-N, N'-diacetate derivative | |
JPS6150908A (en) | Skin cosmetic | |
JPS61100511A (en) | Skin cosmetic | |
JPH0196109A (en) | Skin-beautifying cosmetic | |
JPS6185308A (en) | Skin cosmetic | |
JPS6281307A (en) | Skin cosmetic | |
JPS61151107A (en) | Skin cosmetic | |
JPS62164609A (en) | Skin cosmetic | |
KR100364314B1 (en) | Use of unfermented honey as a depigmenting agent | |
JPH01121205A (en) | Skin beautifying cosmetic | |
JPH0528204B2 (en) | ||
JPS6153209A (en) | Skin cosmetic | |
JPS6023307A (en) | Skin beautifying cosmetic | |
JPH0348883B2 (en) | ||
JPS62226910A (en) | Skin cosmetic | |
JPH0363207A (en) | Skin cosmetic | |
JP3441166B2 (en) | Anti-aging skin cosmetics |